Key Takeaways
- A building year, not a bad year: FY26 revenue grew 12.4% and EBITDA margin expanded 150 bps to 15.3%, but reported PAT was obscured by ₹142 cr of Q4 revenue deferment, portfolio restructuring costs, and a normalized tax charge.
- The Q4 deferment is a timing issue, not demand erosion: ₹142 cr of revenue slipped into FY27 across defense manufacturing (supply chain), strategic electronics (supplier redirection), and aerospace (Akkodis transition). All contracts remain intact and the revenue is now hard visibility for Q1 and Q2 FY27.
- The Akkodis divestment resets the portfolio: The sale of heavy engineering, energy, and automotive practices for USD \$30.63 mn in cash closes in Q2 FY27, generating an extraordinary gain of ~₹175 cr. The retained core (aerospace, defense, ESAI) generated ~₹904 cr at blended EBITDA margins above 20%.
- Power 930 is non-negotiable, but the bridge is conceptual: Management reaffirmed the ₹9,000 cr FY2030 revenue target and framed the path as moving from design services (3% of value) to serial manufacturing (97% of value). No year-by-year growth path was provided.
- What to watch next quarter: Closure of the Akkodis transaction and the associated ₹175 cr gain, recognition of the deferred ₹142 cr revenue, progress on the aerospace manufacturing acquisition, and any quantification of the bid pipeline that management deferred to Q1 results.
The Q4 Deferment: What Moved and Why
- Defense manufacturing (₹45 cr): A critical input material supply disruption affected production timelines on land systems for the Ministry of Defence. The supplier constraint has since been resolved.
- Strategic electronics (₹84 cr): A monopolistic hardware supplier redirected output to war-related priority programs, impacting production. Input materials have since been secured.
- Aerospace and defense (₹12.6 cr): Deferment arose directly from the Akkodis divestment transition; the contract was designated as strategic for retention.
- Cash impact: The deferment, combined with ~₹100 cr of unbilled land systems WIP, drove negative operating cash flow. When these programs deliver and collect in H1 FY27, ~₹120-140 cr of cash will be released. Receivables DSO has already normalized from 130 days to 81 days post-March.
Dr. Sampath Ravinarayanan: "We did not have a bad year, we had a building year. There is a fundamental difference."
Portfolio Restructuring: Akkodis and the Core That Remains
- The Akkodis transaction: Signed 26 May 2026, the divestment of heavy engineering, energy, and automotive practices to Akkodis is a slump sale for USD \$30.63 mn in cash pre-tax. AXISCADES will handhold for one year, then cash out the balance 25% plus earnout. Closure is expected in Q2 FY27 with an extraordinary gain of ~₹175 cr (~₹41 per share EPS).
- Exceptional items: ₹11.17 cr booked in FY26: ₹9.8 cr in transaction restructuring costs for Akkodis, and ₹7.98 cr in fair value adjustment on Epcogen, sold at less than book value. These are portfolio reset costs, not recurring.
- The retained core: After the transaction, core domains generated ~₹904 cr (~78% of consolidated revenue). Aerospace grew 21% YoY to ₹388 cr (17.3% EBITDA margin), defense grew 25% YoY to ₹379 cr (22.9% EBITDA margin), and ESAI grew 9% YoY to ₹136 cr (26.1% EBITDA margin).
- Phase 2 is coming: Management described Phase 2 of the divestment as "much, much, much bigger" than Phase 1 and said it should fund all planned capex and acquisitions without any dilution or borrowing. No fixed timeline was given beyond "well on track."
Dr. Sampath Ravinarayanan: "Phase 2 is going to be a much, much, much bigger thing. So, we will be able to, without any dilution, any borrowing. We should be able to do that."
FY27 Visibility and the Power 930 Ambition
- FY27 revenue trending toward ₹1,377 cr: This represents 52% growth on the retained business base of ₹903 cr. The build-up: ₹927 cr in orders under execution, ₹284-285 cr in assured forecast visibility, and ₹165 cr in acquisition-linked visibility.
- Deferred revenue enters FY27: The ₹142 cr deferred from Q4 FY26 is now hard orders under execution, scheduled for recognition in Q1 and Q2 FY27, subject to delivery, inspection, and customer acceptance.
- Power 930 reaffirmed: The ₹9,000 cr FY2030 revenue target is non-negotiable. Management framed the scaling logic as moving from design services to serial manufacturing: an architect charges 3% of a building's fee, a builder captures 97%. The PAT target of ₹960 cr may be achievable earlier, requiring only ₹7,200 cr revenue at 25%+ EBITDA margin.
- The unanswered bridge: When asked whether the target would be scaled down given FY26 revenue of ~₹900 cr (a 10x jump in four years), management did not provide a quantified bridge or year-by-year growth path, stating only that real momentum starts this year.
Dr. Sampath Ravinarayanan: "We are not scaling it down, we are sticking to 9000."
Xida, Space, and the ESAI Scale-Up
- Xida Inc. created: An American-led, Silicon Valley-headquartered deep tech and AI company, structured as a subsidiary of AXISCADES. The existing ESAI business will move into Xida, giving it immediate revenue, customers, and credibility.
- ESAI acquisition in final stages: A Vietnamese US company is being evaluated for acquisition, which would give Xida locations in the US, Vietnam, and India. One more ESAI acquisition (~₹150 cr) is also planned.
- Customer expansion in ESAI: The largest consumer electronics company in the world has been enrolled as a design-cum-manufacturing MSA (previously only design). Qualcomm engagement has yielded a USD \$3.5 mn order in 2-3 months with a pipeline carrying a monthly run rate of USD \$0.5-1 mn. One large hyperscaler is also engaging.
- Space division established: A space situational awareness initiative with Aldoria is underway. Strategic partnerships for space bus and space payload manufacturing are being evaluated at the Devanahalli campus. Infrastructure building has started.
Manufacturing Infrastructure and Acquisitions
- Devanahalli and Hyderabad campuses: The Devanahalli campuses and the missile Atmanirbhar complex (MAC) in Hyderabad will become operational through FY27. Expansion beyond them has been initiated. By year-end, DAL will be ready, and DAC and MAC will be ready to start complete manufacturing.
- Aerospace manufacturing acquisition: A non-binding offer has been given for an aerospace manufacturing acquisition that comes with a very good order book. It is expected to jumpstart high-value manufacturing activities in Q3 FY27.
- Acquisition pipeline post-Phase 2: Four acquisitions are planned: two in ESAI (~₹50 cr and ~₹150 cr) and two in aerospace (~₹400-450 cr). Combined with Phase 1 and Phase 2 divestment proceeds, management expects to cover ~80% of total capex plus acquisitions (~₹2,100-2,250 cr) with the balance from internal accruals, partnerships, or JVs. No equity dilution is planned.
- OEM relationships: Offset obligations were abolished in 2025; all new contracts are toward "making India Atmanirbhar." Contracts and JVs with two major OEMs are expected to complete around Q3. Dr. SRN was in France to discuss and handshake.
Margins, Cash, and the Balance Sheet
- FY26 margin expansion: EBITDA margin expanded 150 bps to 15.3%, with EBITDA growing 24.6% on 12.4% revenue growth. Core verticals already average above 20% EBITDA.
- FY27 margin target: Management is targeting at least 150-200 bps improvement year-on-year on core verticals, with a ceiling around 25-27% EBITDA. Aerospace manufacturing is expected to help achieve an average of ~23% EBITDA.
- Tax normalization: FY26 tax charge was ₹42 cr vs ₹12 cr in FY25. FY25 included a one-time reversal of ₹10.01 cr. FY26 reflects a normalized position with a higher average rate (36%) due to higher tax rates in overseas entities and inability to recognize a deferred tax asset in a loss-making German entity.
- Borrowings: Gross borrowings increased by ₹87 cr (to ₹276 cr) for project-specific working capital for land systems. Returns are expected as program invoices flow from Q2 FY27.
- ESOP plan: Total ESOP cost is ~₹54 cr. By Q1 and Q2 FY27, management expects to award the entire 0.38 cr ESOPs, aligned with the ₹175 cr extraordinary income from the Akkodis transaction. The plan needs recalibration after headcount reduction from 2,800 to ~1,200.
Dr. Sampath Ravinarayanan: "In the short run, the market is a voting machine. In the long run, it is a weighing machine. I would urge every investor in this room to weigh what we have built, not vote on one quarter."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Akkodis divestment closure | Transaction close; extraordinary gain of ~₹175 cr (~₹41 per share EPS) | Q2 FY27 |
| Deferred revenue recognition | ₹142 cr recognized as revenue, subject to delivery, inspection, and customer acceptance | Q1 and Q2 FY27 |
| Land systems dispatch and cash release | Pre-dispatch inspection by MoD in progress; ~₹120-140 cr cash released on delivery and collection | Q1-Q2 FY27 |
| Aerospace manufacturing acquisition | Jumpstart high-value manufacturing activities | Q3 FY27 |
| Devanahalli and Hyderabad infrastructure | DAL, DAC, and MAC operational; complete manufacturing begins | By year-end FY27 |
| Core vertical EBITDA margin improvement | At least 150-200 bps improvement year-on-year | FY27 |
| ESOP issuance | Award entire 0.38 cr ESOPs | By Q2 FY27 |
| OEM contracts and JVs | Complete with two major OEMs | Around Q3 FY27 |
| Power 930 revenue target | ₹9,000 cr revenue | FY2030 |
Key Metrics
| Metric | Q4 FY26 / FY26 |
|---|---|
| Full-year revenue | ₹1,159 cr, 12.4% growth YoY |
| Full-year EBITDA | ₹178 cr, 24.6% growth YoY |
| Full-year EBITDA margin | 15.3%, 150 bps expansion YoY |
| Full-year PBT before exceptional items | ₹125 cr, 36.5% growth YoY |
| Full-year reported PAT | ₹72 cr, ~4.3% degrowth YoY |
| Full-year normalized PAT | ₹83 cr, 27.6% growth YoY (vs normalized FY25 PAT of ₹65 cr) |
| Q4 reported revenue | ₹273 cr |
| Q4 EBITDA | ₹34 cr |
| Q4 PAT | ₹0.4 cr |
| Q4 revenue deferment | ₹142 cr, with EBITDA impact of more than ₹40 cr; moved into FY27 visibility |
| Exceptional items impact | ₹11.17 cr, comprising transaction restructuring cost of ₹9.8 cr and fair value adjustment on divested business of ₹7.98 cr |
| Akkodis divestment value | \$30.63 million in cash pre-tax; expected extraordinary gain of ~₹175 cr on closure |
| FY27 consolidated revenue visibility | ₹1,377 cr, representing 52% growth on retained business base of ₹903 cr in FY26 |
| Orders under execution | ₹927 cr, includes the ₹142 cr deferred from Q4 FY26 |
| Assured forecast visibility | ₹284-285 cr, programs with qualified sole source or limited source supplier status |
| Acquisition-linked visibility | ₹165 cr, comprising ESAI and aerospace acquisition components |
| Aerospace FY26 revenue | ₹388 cr, 21% growth YoY, 17.3% EBITDA margin |
| Defense FY26 revenue | ₹379 cr, 25% growth YoY, 22.9% EBITDA margin |
| ESAI FY26 revenue | ₹136 cr, 9% growth YoY, 26.1% EBITDA margin |
| Core domains share of consolidated revenue | ~78%, ~₹904 cr in FY26 |
| Closing receivables | ₹411 cr, DSO of 130 days; ₹154.5 cr collected since March, DSO now 81 days |
| Gross borrowings | ₹276 cr, increased by ₹87 cr from ₹189 cr for land systems working capital |
| Consolidated net worth | ₹734 cr |
| Total assets | ₹1,466 cr, up from ₹1,127 cr |
| Land systems WIP | ~₹100 cr, classified under other assets; 20 units ready for dispatch, 25 at assembly, 85 in production |
| Power 930 revenue target | ₹9,000 cr by FY2030 |
| Power 930 PAT target | ₹960 cr by FY2030 |
| Qualcomm order | \$3.5 million in 2-3 months; monthly run rate pipeline of \$0.5 million to \$1 million |